Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 34Sarcoma 11Gastrointestinal 2Thoracic 1Other solid neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Endocrine 1Classical hematology 1

Conditions

Leukemia 28Myelodysplastic Syndromes 26Anemia, Refractory, with Excess of Blasts 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Leukemia, Myeloid, Chronic-Phase 19Leukemia, Myelomonocytic, Chronic 16Leukemia, Myeloid, Accelerated Phase 16Myeloproliferative Disorders 15Leukemia, Myeloid, Acute 15Anemia, Refractory 15Lymphoma 14Congenital Abnormalities 13Burkitt Lymphoma 13Myelodysplastic-Myeloproliferative Diseases 12Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 12Dendritic Cell Sarcoma, Interdigitating 12Lymphoma, Non-Hodgkin 11Lymphoma, Follicular 11Leukemia, Lymphocytic, Chronic, B-Cell 11Lymphoma, Mantle-Cell 10Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, Large B-Cell, Diffuse 10Graft vs Host Disease 10Blast Crisis 10Recurrence 9Multiple Myeloma 8Lymphoma, B-Cell, Marginal Zone 8Primary Myelofibrosis 7Leukemia, Myelomonocytic, Juvenile 7Hodgkin Disease 7

Interventions

Temozolomide 1Radiotherapy 1Comparative Genomic Hybridization 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oligodendroglioma × Radiotherapy × Classical hematology × Clear all
NCT00471653 2018-07-09

Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Terminated
10 enrolled
CNSClassical hematologySarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Thrombocytopenia, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡